需要上颌骨切除术的晚期鳞状细胞癌的术后放疗
这项回顾性分析基于2004至2019年美国国家癌症数据库,纳入416例接受上颌骨切除术及颈清扫的pTa4N0期上颌牙龈或硬腭鳞状细胞癌患者。结果显示,术后放疗与生存改善相关(aHR 0.50,95%CI 0.32-0.81),但亚组分析中仅肿瘤≥2 cm者获益(aHR 0.47,95%CI 0.29-0.77),肿瘤<2 cm者未见生存获益(aHR 1.15,95%CI 0.33-4.08)。
要点
- pTa4N0期上颌牙龈或硬腭鳞癌行上颌骨切除术后,49.3%患者接受术后放疗。
- 术后放疗与手术相比,生存风险比aHR为0.50(95%CI 0.32-0.81)。
- 肿瘤≥2 cm者术后放疗aHR为0.47,肿瘤<2 cm者aHR为1.15,后者未达统计学显著。
核心结论
- 绝大多数pTa4aN0期侵犯骨的上颌牙龈和硬腭鳞状细胞癌患者从术后放疗中获益。
- 肿瘤<2 cm的患者未显示辅助治疗的生存获益,提示单纯骨侵犯可能不足以作为治疗升级的标准。
研究设计与样本
- 回顾性分析,数据来自2004至2019年美国国家癌症数据库,纳入416例接受上颌骨切除术(部分、次全或全切)及颈清扫的初治、切缘阴性pTa4aN0期上颌牙龈或硬腭鳞状细胞癌成人患者。
- 采用逆概率加权并入多因素Cox比例风险模型,调整年龄、性别、种族、保险状态、收入、教育、城乡、机构类型、地区、合并症指数、肿瘤分级和肿瘤延伸。
- 按肿瘤大小进行预先设定的亚组分析。
主要发现
- 416例患者平均(标准差)年龄71.5(11.3)岁;男性190例(45.7%);肿瘤大小2 cm者362例(87%)。
- 总体49.3%的患者(205例)接受术后放疗。
- 术后放疗与单纯手术相比,生存改善50%(aHR 0.50;95%CI 0.32-0.81)。
- 亚组分析中,肿瘤≥2 cm者术后放疗与生存改善相关(aHR 0.47;95%CI 0.29-0.77)。
- 肿瘤<2 cm者术后放疗未显示生存获益(aHR 1.15;95%CI 0.33-4.08)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate whether postoperative radiotherapy (PORT) improves survival among patients who received maxillectomy for pT4aN0 maxillary gingival or hard palate squamous cell carcinoma (SCC) with respect to tumor size. STUDY DESIGN: Retrospective analysis. SETTING: National Cancer Database from 2004 to 2019. METHODS: Included adult patients who received maxillectomy (partial, subtotal, or total) and neck dissection for treatment-naive margin negative pT4aN0 SCC of the maxillary gingiva or hard palate. Adjusted for age, gender, race, insurance status, income, education, urban/rural, facility type, region, comorbidity index, tumor grade, and tumor extension. Inverse probability weights were incorporated into a multivariable Cox proportional hazards model. A priori post hoc subgroup analysis was performed according to tumor size. RESULTS: We included 416 patients who underwent maxillectomy for pT4aN0 SCC of the maxillary gingiva or hard palate (mean [standard deviation] age, 71.5 [11.3] years; male, 190 [45.7%]; tumor size 2 cm, 362 [87%]). Overall, 49.3% of patients received PORT (205 patients). PORT was associated with a 50% improvement in survival compared to surgery alone (adjusted hazard ratio [aHR], 0.50; 95% confidence interval [95% CI], 0.32-0.81). On subgroup analysis, PORT was associated with improved survival for tumors 2 cm (aHR, 0.47; 95% CI, 0.29-0.77), but not for tumors < 2 cm (aHR, 1.15; 95% CI, 0.33-4.08). CONCLUSION: The vast majority of patients with pT4aN0 bone-invading SCC of the maxillary gingiva and hard palate benefit from PORT. Patients with tumors < 2 cm did not demonstrate a survival benefit from adjuvant treatment, suggesting that bony invasion alone may not be sufficient criteria for treatment escalation.
引用
- Harley RJ, Spector ME, Wilke CT, et al. Postoperative Radiotherapy in Advanced Stage Squamous Cell Carcinoma Requiring Maxillectomy. Otolaryngol Head Neck Surg. 2024. PMID: 39016093. doi:10.1002/ohn.896
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。